Investigation of Cardiac Function Following Low-Intensity Ultrasound Intervention
1 other identifier
interventional
6
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the influence of ultrasound on cardiac functrion. The main question it aims to answer is: How will ultrasound affect the cardiac function? Researchers will: Apply ultrasound to the body and observe cardiac functions. Participants will: Receive ultrasound application and physiological signal monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2024
CompletedFirst Posted
Study publicly available on registry
August 22, 2024
CompletedStudy Start
First participant enrolled
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 10, 2027
November 4, 2024
October 1, 2024
3 years
August 14, 2024
October 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Heart rhythm.
Monitor participants' electrocardiogram before, during and after ultrasound application. Calculate heart rate from the electrocardiogram signal. The change of heart rate is calculated as the rate of change relative to the baseline heart rate. Aggregate the data and do statistical analysis. Data will be presented as mean with standard deviations.
Throughout the intervention, an average of 1 hour.
Incidence of treatment-related adverse events.
The incidence of treatment-related adverse events includes both minor (such as localized discomfort, transient arrhythmias, mild chest pain, short-term dizziness, nausea, and temporary shortness of breath) and severe adverse events (including sustained arrhythmias, new-onset heart failure, significant myocardial injury, embolic events, or death).
Baseline, during the intervention (an average of 1 hour) and immediately after the intervention (same day, approximately 1 hour after baseline).
Study Arms (4)
Ultrasound application at minimal intensity
EXPERIMENTALApply minimal-intensity ultrasound to the participant. The intensity is below 2 W/cm².
Ultrasound application at mild intensity
EXPERIMENTALApply mild-intensity ultrasound to the participant. The intensity is below 3 W/cm².
Ultrasound application at medium intensity
SHAM COMPARATORApply medium-intensity ultrasound to the participant. The intensity is below 5 W/cm².
No ultrasound application
SHAM COMPARATORNo ultrasound application to the participant.
Interventions
Apply ultrasound to the participant within a safe range.
No ultrasound application to the participant.
Eligibility Criteria
You may qualify if:
- Healthy individuals without significant diseases or chronic conditions.
- Aged between 18 and 65 years.
- Voluntary participation with signed informed consent.
- No history of cardiovascular disease.
You may not qualify if:
- Individuals with heart disease or other conditions that may affect cardiac function measurement.
- Individuals with implanted electronic devices such as pacemakers or defibrillators.
- Those on medications that significantly alter heart rate, such as beta-blockers, unless under stable control for a specific period.
- Individuals at risk of severe complications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bingbing Cheng
Shanghai, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcomes assessors are blinded to the experimental condition.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 14, 2024
First Posted
August 22, 2024
Study Start
October 10, 2024
Primary Completion (Estimated)
October 10, 2027
Study Completion (Estimated)
October 10, 2027
Last Updated
November 4, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share